VHIO ‘on the ground’ at ASH 2021: seeking out more effective treatment strategies against B-cell lymphomas

by VHIO

Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most common subtype of non-Hodgkin lymphoma (NHL), accounting for about 30% of B-cell NHL, with an estimated 8,500 new cases each ...

Read more

Nuevo ciclo de conferencias para acercar la investigación y la actividad asistencial a las personas con cáncer y sus familias en Vall d’Hebron

by VHIO

Un año más, el Vall d’Hebron Instituto de Oncología (VHIO) y el Hospital Universitario Vall d’Hebron (HUVH) han programado un ciclo de jornadas online para 2022 en las que se abordarán diferen...

Read more

La Clínica Universidad de Navarra, único centro que ensaya un tratamiento que reduciría al mínimo el contagio por Covid-19

by Clínica Universidad de Navarra

Un sistema para la fotodesinfección nasal podría eliminar el reservorio del virus en la nariz del paciente contagiado, evitando así que infecte a otras personas.

Read more

ORYZON announces approval for Serbian arm of PORTICO, vafidemstat’s Phase IIb trial in Borderline Personality Disorder

by Oryzon Genomics

PORTICO (EudraCT No.: 2020-003469-20, ClinicalTrials.gov Identifier NCT04932291) is a multicenter, double-blind, randomized, placebo-controlled, Phase IIb trial to evaluate the efficacy and safety of ...

Read more

Dos ensayos internacionales ofrecen nuevas alternativas para pacientes de cáncer de hígado

by CIBEREHD-Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Dos ensayos clínicos internacionales liderados por la Clínica Universidad de Navarra ofrecen una alternativa terapéutica –el fármaco nivolumab- para los pacientes con cáncer de hígado que no s...

Read more

NorthSea Therapeutics, supported by Ysios Capital, Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease

by Ysios Capital

NorthSea Therapeutics B.V., (‘NST’), a biotech company developing novel and innovative strategies for the treatment of NASH and other metabolic diseases, announces it has initiated a Phase 1 stud...

Read more

People with schizophrenia who participate in clinical trials may not be representative of the population suffering from this disease

by Instituto de Investigación e Innovación Parc Taulí

An international study led by I3PT notes that clinical trials may account for only about one-fifth of people in the real world with schizophrenia spectrum disorders, and points out that new studies sh...

Read more

Recuperan un antibiótico 'olvidado' para infecciones de bacterias resistentes

by Instituto de Biomedicina de Sevilla - IBIS

Investigadores del IBiS, liderados por el Dr. Jesús Rodríguez Baño del IBiS/CSIC/US, facultativos de Enfermedades Infecciosas y Microbiología en el Hospital Universitario Virgen Macarena y CIBERIN...

Read more

A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma

by Fundació Clínic per a la Recerca Biomèdica

A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinical forms of mantle cell lymphoma. With this therapy...

Read more

Vall d’Hebron enrolls the first patient in a clinical trial designed to treat locally advanced pancreatic cancer with nanoparticles

by VHIO

The Vall d’Hebron Institute of Oncology (VHIO) has enrolled the first patient in the NoCanTher project’s clinical trial, representing an important step in bringing in nano-driven therapeutics as n...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream